<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39316785</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2369-2960</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>JMIR public health and surveillance</Title><ISOAbbreviation>JMIR Public Health Surveill</ISOAbbreviation></Journal><ArticleTitle>Assessment of the Effective Sensitivity of SARS-CoV-2 Sample Pooling Based on a Large-Scale Screening Experience: Retrospective Analysis.</ArticleTitle><Pagination><StartPage>e54503</StartPage><MedlinePgn>e54503</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e54503</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/54503</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The development of new large-scale saliva pooling detection strategies can significantly enhance testing capacity and frequency for asymptomatic individuals, which is crucial for containing SARS-CoV-2.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aims to implement and scale-up a SARS-CoV-2 screening method using pooled saliva samples to control the virus in critical areas and assess its effectiveness in detecting asymptomatic infections.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Between August 2020 and February 2022, our laboratory received a total of 928,357 samples. Participants collected at least 1 mL of saliva using a self-sampling kit and registered their samples via a smartphone app. All samples were directly processed using AutoMate 2550 for preanalytical steps and then transferred to Microlab STAR, managed with the HAMILTON Pooling software for pooling. The standard pool preset size was 20 samples but was adjusted to 5 when the prevalence exceeded 2% in any group. Real-time polymerase chain reaction (RT-PCR) was conducted using the Allplex SARS-CoV-2 Assay until July 2021, followed by the Allplex SARS-CoV-2 FluA/FluB/RSV assay for the remainder of the study period.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 928,357 samples received, 887,926 (95.64%) were fully processed into 56,126 pools. Of these pools, 4863 tested positive, detecting 5720 asymptomatic infections. This allowed for a comprehensive analysis of pooling's impact on RT-PCR sensitivity and false-negative rate (FNR), including data on positive samples per pool (PPP). We defined Ct<sub>ref</sub> as the minimum cycle threshold (Ct) of each data set from a sample or pool and compared these Ct<sub>ref</sub> results from pooled samples with those of the individual tests (ΔCt<sup>P</sup>). We then examined their deviation from the expected offset due to dilution [ΔΔCt<sup>P</sup> = ΔCt<sup>P</sup> - log<sub>2</sub>]. In this work, the ΔCt<sup>P</sup> and ΔΔCt<sup>P</sup> were 2.23 versus 3.33 and -0.89 versus 0.23, respectively, comparing global results with results for pools with 1 positive sample per pool. Therefore, depending on the number of genes used in the test and the size of the pool, we can evaluate the FNR and effective sensitivity (1 - FNR) of the test configuration. In our scenario, with a maximum of 20 samples per pool and 3 target genes, statistical observations indicated an effective sensitivity exceeding 99%. From an economic perspective, the focus is on pooling efficiency, measured by the effective number of persons that can be tested with 1 test, referred to as persons per test (PPT). In this study, the global PPT was 8.66, reflecting savings of over 20 million euros (US $22 million) based on our reagent prices.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results demonstrate that, as expected, pooling reduces the sensitivity of RT-PCR. However, with the appropriate pool size and the use of multiple target genes, effective sensitivity can remain above 99%. Saliva pooling may be a valuable tool for screening and surveillance in asymptomatic individuals and can aid in controlling SARS-CoV-2 transmission. Further studies are needed to assess the effectiveness of these strategies for SARS-CoV-2 and their application to other microorganisms or biomarkers detected by PCR.</AbstractText><CopyrightInformation>©Jorge J Cabrera Alvargonzalez, Ana Larrañaga, Javier Martinez, Sonia Pérez Castro, Sonia Rey Cao, Carlos Daviña Nuñez, Víctor Del Campo Pérez, Carmen Duran Parrondo, Silvia Suarez Luque, Elena González Alonso, Alfredo José Silva Tojo, Jacobo Porteiro, Benito Regueiro. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 24.09.2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cabrera Alvargonzalez</LastName><ForeName>Jorge J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0002-0397-0868</Identifier><AffiliationInfo><Affiliation>Microbiology Department, Complexo Hospitalario Universitario de Vigo, Servicio Galego de Saude, Vigo, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Galicia Sur Health Research Institute (IIS Galicia Sur), Microbiology and Infectology Research Group, Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larrañaga</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4738-7180</Identifier><AffiliationInfo><Affiliation>Centro de Investigación en Tecnologías, Energía y Procesos Industriales, University of Vigo, Lagoas-Marcosende, Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6359-895X</Identifier><AffiliationInfo><Affiliation>Applied Mathematics I, Telecommunications Engineering School, University of Vigo, Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pérez Castro</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1734-1904</Identifier><AffiliationInfo><Affiliation>Microbiology Department, Complexo Hospitalario Universitario de Vigo, Servicio Galego de Saude, Vigo, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Galicia Sur Health Research Institute (IIS Galicia Sur), Microbiology and Infectology Research Group, Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rey Cao</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6996-3951</Identifier><AffiliationInfo><Affiliation>Microbiology Department, Complexo Hospitalario Universitario de Vigo, Servicio Galego de Saude, Vigo, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Galicia Sur Health Research Institute (IIS Galicia Sur), Microbiology and Infectology Research Group, Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daviña Nuñez</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6952-2219</Identifier><AffiliationInfo><Affiliation>Galicia Sur Health Research Institute (IIS Galicia Sur), Microbiology and Infectology Research Group, Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Campo Pérez</LastName><ForeName>Víctor</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-9424-9653</Identifier><AffiliationInfo><Affiliation>Department of Preventive Medicine and Public Health, Complexo Hospitalario, Universitario de Vigo, Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duran Parrondo</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0007-6850-9080</Identifier><AffiliationInfo><Affiliation>Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suarez Luque</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0003-9840-6796</Identifier><AffiliationInfo><Affiliation>Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>González Alonso</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0009-0002-8024-3397</Identifier><AffiliationInfo><Affiliation>Galicia Sur Health Research Institute (IIS Galicia Sur), Microbiology and Infectology Research Group, Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva Tojo</LastName><ForeName>Alfredo José</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0009-0003-4980-7892</Identifier><AffiliationInfo><Affiliation>Dirección Xeral de Maiores y atención Sociosanitaria, Conselleria de Politica Social e Xuventude, Xunta de Galicia, Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porteiro</LastName><ForeName>Jacobo</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2197-3269</Identifier><AffiliationInfo><Affiliation>Centro de Investigación en Tecnologías, Energía y Procesos Industriales, University of Vigo, Lagoas-Marcosende, Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regueiro</LastName><ForeName>Benito</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-4009-7922</Identifier><AffiliationInfo><Affiliation>Microbiology Department, Complexo Hospitalario Universitario de Vigo, Servicio Galego de Saude, Vigo, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Galicia Sur Health Research Institute (IIS Galicia Sur), Microbiology and Infectology Research Group, Vigo, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Public Health Surveill</MedlineTA><NlmUniqueID>101669345</NlmUniqueID><ISSNLinking>2369-2960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012463" MajorTopicYN="Y">Saliva</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="Y">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="Y">Mass Screening</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013048" MajorTopicYN="N">Specimen Handling</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000087123" MajorTopicYN="N">COVID-19 Nucleic Acid Testing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PCR</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">nonsymptomatic</Keyword><Keyword MajorTopicYN="N">pooling</Keyword><Keyword MajorTopicYN="N">saliva</Keyword><Keyword MajorTopicYN="N">screening</Keyword><Keyword MajorTopicYN="N">sensitivity</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword><Keyword MajorTopicYN="N">transmission control</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>16</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39316785</ArticleId><ArticleId IdType="pmc">PMC11462102</ArticleId><ArticleId IdType="doi">10.2196/54503</ArticleId><ArticleId IdType="pii">v10i1e54503</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  WHO COVID-19 dashboard. data.who.int.  [2023-08-15].  
 https://data.who.int/dashboards/covid19/cases?n=c
.</Citation></Reference><Reference><Citation>Ferretti L, Wymant C, Kendall M, Zhao L, Nurtay A, Abeler-Dörner Lucie, Parker M, Bonsall D, Fraser C. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science. 2020 May 08;368(6491):6936. doi: 10.1126/science.abb6936. 
 
science.abb6936</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb6936?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1126/science.abb6936</ArticleId><ArticleId IdType="pmc">PMC7164555</ArticleId><ArticleId IdType="pubmed">32234805</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TW, Munday JD, Kucharski AJ, Edmunds WJ, Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group. Funk S, Eggo RM. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health. 2020 Apr;8(4):e488–e496. doi: 10.1016/S2214-109X(20)30074-7. 
 
S2214-109X(20)30074-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(20)30074-7</ArticleId><ArticleId IdType="pmc">PMC7097845</ArticleId><ArticleId IdType="pubmed">32119825</ArticleId></ArticleIdList></Reference><Reference><Citation>Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill. 2020 Jan;25(4):2000058. doi: 10.2807/1560-7917.ES.2020.25.4.2000058. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.4.2000058</ArticleId><ArticleId IdType="pmc">PMC7001239</ArticleId><ArticleId IdType="pubmed">32019669</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi M, Yokoe DS, Havlir DV. Asymptomatic transmission, the Achilles' heel of current strategies to control Covid-19. N Engl J Med. 2020 May 28;382(22):2158–2160. doi: 10.1056/NEJMe2009758. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2009758</ArticleId><ArticleId IdType="pmc">PMC7200054</ArticleId><ArticleId IdType="pubmed">32329972</ArticleId></ArticleIdList></Reference><Reference><Citation>Syangtan G, Bista S, Dawadi P, Rayamajhee B, Shrestha LB, Tuladhar R, Joshi DR. Asymptomatic SARS-CoV-2 carriers: a systematic review and meta-analysis. Front Public Health. 2020 Jan 20;8:587374. doi: 10.3389/fpubh.2020.587374. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.587374</ArticleId><ArticleId IdType="pmc">PMC7855302</ArticleId><ArticleId IdType="pubmed">33553089</ArticleId></ArticleIdList></Reference><Reference><Citation>Alene M, Yismaw L, Assemie MA, Ketema DB, Mengist B, Kassie B, Birhan TY. Magnitude of asymptomatic COVID-19 cases throughout the course of infection: a systematic review and meta-analysis. PLoS One. 2021;16(3):e0249090. doi: 10.1371/journal.pone.0249090. 
 
PONE-D-20-28251</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249090</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0249090</ArticleId><ArticleId IdType="pmc">PMC7987199</ArticleId><ArticleId IdType="pubmed">33755688</ArticleId></ArticleIdList></Reference><Reference><Citation>Woloshin S, Patel N, Kesselheim AS. False negative tests for SARS-CoV-2 infection - challenges and implications. N Engl J Med. 2020 Aug 06;383(6):e38. doi: 10.1056/NEJMp2015897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2015897</ArticleId><ArticleId IdType="pubmed">32502334</ArticleId></ArticleIdList></Reference><Reference><Citation>Larremore DB, Wilder B, Lester E, Shehata S, Burke JM, Hay JA, Tambe M, Mina MJ, Parker R. Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening. Sci Adv. 2021 Jan;7(1):eabd5393. doi: 10.1126/sciadv.abd5393. 
 
sciadv.abd5393</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd5393?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1126/sciadv.abd5393</ArticleId><ArticleId IdType="pmc">PMC7775777</ArticleId><ArticleId IdType="pubmed">33219112</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina MJ, Parker R, Larremore DB. Rethinking Covid-19 test sensitivity - a strategy for containment. N Engl J Med. 2020 Nov 26;383(22):e120. doi: 10.1056/NEJMp2025631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2025631</ArticleId><ArticleId IdType="pubmed">32997903</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina MJ, Andersen KG. COVID-19 testing: one size does not fit all. Science. 2021 Jan 08;371(6525):126–127. doi: 10.1126/science.abe9187.science.abe9187</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe9187</ArticleId><ArticleId IdType="pubmed">33414210</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Alvargonzalez JJ, Rey Cao S, Pérez Castro Sonia, Martinez Lamas L, Cores Calvo O, Torres Piñon Julio, Porteiro Fresco J, Garcia Comesaña Julio, Regueiro Garcia B. Pooling for SARS-CoV-2 control in care institutions. BMC Infect Dis. 2020 Oct 12;20(1):745. doi: 10.1186/s12879-020-05446-0. 
 
10.1186/s12879-020-05446-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05446-0</ArticleId><ArticleId IdType="doi">10.1186/s12879-020-05446-0</ArticleId><ArticleId IdType="pmc">PMC7549089</ArticleId><ArticleId IdType="pubmed">33046011</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdalhamid B, Bilder CR, McCutchen EL, Hinrichs SH, Koepsell SA, Iwen PC. Assessment of specimen pooling to conserve SARS CoV-2 testing resources. Am J Clin Pathol. 2020 May 05;153(6):715–718. doi: 10.1093/ajcp/aqaa064. 
 
5822023</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/aqaa064</ArticleId><ArticleId IdType="pmc">PMC7188150</ArticleId><ArticleId IdType="pubmed">32304208</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanel R, Thurner S. Boosting test-efficiency by pooled testing for SARS-CoV-2-formula for optimal pool size. PLoS One. 2020 Nov 4;15(11):e0240652. doi: 10.1371/journal.pone.0240652. 
 
PONE-D-20-13830</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240652</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0240652</ArticleId><ArticleId IdType="pmc">PMC7641378</ArticleId><ArticleId IdType="pubmed">33147228</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbantoglu OU. Group testing performance evaluation for SARS-CoV-2 massive scale screening and testing. BMC Med Res Methodol. 2020 Jul 02;20(1):176. doi: 10.1186/s12874-020-01048-1. 
 
10.1186/s12874-020-01048-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-020-01048-1</ArticleId><ArticleId IdType="doi">10.1186/s12874-020-01048-1</ArticleId><ArticleId IdType="pmc">PMC7330001</ArticleId><ArticleId IdType="pubmed">32615934</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogan CA, Sahoo MK, Pinsky BA. Sample pooling as a strategy to detect community transmission of SARS-CoV-2. JAMA. 2020 May 19;323(19):1967–1969. doi: 10.1001/jama.2020.5445. 
 
2764364</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.5445</ArticleId><ArticleId IdType="pmc">PMC7136853</ArticleId><ArticleId IdType="pubmed">32250394</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin I, Aharony N, Tamar ES, Argoetti A, Messer E, Berenbaum D, Shafran E, Kuzli A, Gandali N, Shkedi O, Hashimshony T, Mandel-Gutfreund Y, Halberthal M, Geffen Y, Szwarcwort-Cohen M, Kishony R. Evaluation of COVID-19 RT-qPCR test in multi sample pools. Clin Infect Dis. 2020 Nov 19;71(16):2073–2078. doi: 10.1093/cid/ciaa531. 
 
5828059</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa531</ArticleId><ArticleId IdType="pmc">PMC7197588</ArticleId><ArticleId IdType="pubmed">32358960</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Ami R, Klochendler A, Seidel M, Sido T, Gurel-Gurevich O, Yassour M, Meshorer E, Benedek G, Fogel I, Oiknine-Djian E, Gertler A, Rotstein Z, Lavi B, Dor Y, Wolf DG, Salton M, Drier Y, Hebrew University-Hadassah COVID-19 Diagnosis Team  Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection. Clin Microbiol Infect. 2020 Sep;26(9):1248–1253. doi: 10.1016/j.cmi.2020.06.009. 
 
S1198-743X(20)30349-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.06.009</ArticleId><ArticleId IdType="pmc">PMC7308776</ArticleId><ArticleId IdType="pubmed">32585353</ArticleId></ArticleIdList></Reference><Reference><Citation>Wacharapluesadee S, Kaewpom T, Ampoot W, Ghai S, Khamhang W, Worachotsueptrakun K, Wanthong P, Nopvichai C, Supharatpariyakorn T, Putcharoen O, Paitoonpong L, Suwanpimolkul G, Jantarabenjakul W, Hemachudha P, Krichphiphat A, Buathong R, Plipat T, Hemachudha T. Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19. J Med Virol. 2020 Oct 21;92(10):2193–2199. doi: 10.1002/jmv.26005. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26005</ArticleId><ArticleId IdType="pmc">PMC7272832</ArticleId><ArticleId IdType="pubmed">32401343</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres I, Albert E, Navarro D. Pooling of nasopharyngeal swab specimens for SARS-CoV-2 detection by RT-PCR. J Med Virol. 2020 Nov 02;92(11):2306–2307. doi: 10.1002/jmv.25971. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25971</ArticleId><ArticleId IdType="pmc">PMC7267454</ArticleId><ArticleId IdType="pubmed">32369202</ArticleId></ArticleIdList></Reference><Reference><Citation>Santiago I. Trends and innovations in biosensors for COVID-19 mass testing. Chembiochem. 2020 Oct 15;21(20):2880–2889. doi: 10.1002/cbic.202000250. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbic.202000250</ArticleId><ArticleId IdType="pmc">PMC7687022</ArticleId><ArticleId IdType="pubmed">32367615</ArticleId></ArticleIdList></Reference><Reference><Citation>National Center for Immunization and Respiratory Diseases (US)  Interim guidance for use of pooling procedures in SARS-CoV-2 diagnostic, screening, and surveillance testing. Centers for Disease Control and Prevention. 2020. Jul 23,  [2024-08-15].  
 https://stacks.cdc.gov/view/cdc/90937
.</Citation></Reference><Reference><Citation>Shuren Jeff. Coronavirus (COVID-19) update: facilitating diagnostic test availability for asymptomatic testing and sample pooling. Food and Drug Administration (FDA) 2020. Jun 16,  [2024-08-15].  
 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-facilitating-diagnostic-test-availability-asymptomatic-testing-and
.</Citation></Reference><Reference><Citation>Moisset X, Gautier N, Godet T, Parabère Solène, Pereira B, Meunier E, Gerbaud L, Lesens O, Henquell C, Beytout J, Clavelou P. Nasopharyngeal swab-induced pain for SARS-CoV-2 screening: a randomised controlled trial of conventional and self-swabbing. Eur J Pain. 2021 Apr;25(4):924–929. doi: 10.1002/ejp.1722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1722</ArticleId><ArticleId IdType="pubmed">33394524</ArticleId></ArticleIdList></Reference><Reference><Citation>To KK, Lu L, Yip CC, Poon RW, Fung AM, Cheng A, Lui DH, Ho DT, Hung IF, Chan K, Yuen K. Additional molecular testing of saliva specimens improves the detection of respiratory viruses. Emerg Microbes Infect. 2017 Jun 07;6(6):e49. doi: 10.1038/emi.2017.35. 
 
emi201735</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2017.35</ArticleId><ArticleId IdType="doi">10.1038/emi.2017.35</ArticleId><ArticleId IdType="pmc">PMC5520312</ArticleId><ArticleId IdType="pubmed">28588283</ArticleId></ArticleIdList></Reference><Reference><Citation>To K, Yip C, Lai C, Wong C, Ho D, Pang P, Ng A, Leung K, Poon R, Chan K, Cheng V, Hung I, Yuen K. Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study. Clin Microbiol Infect. 2019 Mar;25(3):372–378. doi: 10.1016/j.cmi.2018.06.009. 
 
S1198-743X(18)30468-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2018.06.009</ArticleId><ArticleId IdType="pubmed">29906597</ArticleId></ArticleIdList></Reference><Reference><Citation>Martínez Lamas Lucía, Diz Dios P, Pérez Rodríguez Maria Teresa, Del Campo Pérez Victor, Cabrera Alvargonzalez JJ, López Domínguez Ana María, Fernandez Feijoo J, Diniz Freitas M, Limeres Posse J. Is povidone iodine mouthwash effective against SARS-CoV-2? First in vivo tests. Oral Dis. 2022 Apr;28 Suppl 1(Suppl 1):908–911. doi: 10.1111/odi.13526. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/odi.13526</ArticleId><ArticleId IdType="pmc">PMC7362147</ArticleId><ArticleId IdType="pubmed">32615642</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyllie AL, Fournier J, Casanovas-Massana A, Campbell M, Tokuyama M, Vijayakumar P, Warren JL, Geng B, Muenker MC, Moore AJ, Vogels CB, Petrone ME, Ott IM, Lu P, Venkataraman A, Lu-Culligan A, Klein J, Earnest R, Simonov M, Datta R, Handoko R, Naushad N, Sewanan LR, Valdez J, White EB, Lapidus S, Kalinich CC, Jiang X, Kim DJ, Kudo E, Linehan M, Mao T, Moriyama M, Oh JE, Park A, Silva J, Song E, Takahashi T, Taura M, Weizman O, Wong P, Yang Y, Bermejo S, Odio CD, Omer SB, Dela Cruz CS, Farhadian S, Martinello RA, Iwasaki A, Grubaugh ND, Ko AI. Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2. N Engl J Med. 2020 Sep 24;383(13):1283–1286. doi: 10.1056/NEJMc2016359. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2016359</ArticleId><ArticleId IdType="pmc">PMC7484747</ArticleId><ArticleId IdType="pubmed">32857487</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler-Laporte G, Lawandi A, Schiller I, Yao M, Dendukuri N, McDonald EG, Lee TC. Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis. JAMA Intern Med. 2021 Mar 01;181(3):353–360. doi: 10.1001/jamainternmed.2020.8876. 
 
2775397</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.8876</ArticleId><ArticleId IdType="pmc">PMC7811189</ArticleId><ArticleId IdType="pubmed">33449069</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasomsub E, Watcharananan SP, Boonyawat K, Janchompoo P, Wongtabtim G, Suksuwan W, Sungkanuparph S, Phuphuakrat A. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study. Clin Microbiol Infect. 2021 Feb;27(2):285.e1–285.e4. doi: 10.1016/j.cmi.2020.05.001. 
 
S1198-743X(20)30278-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7227531</ArticleId><ArticleId IdType="pubmed">32422408</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhikara K, Kanta P, Ghosh A, Prakash RC, Goyal K, Singh MP. Validation of SARS CoV-2 detection by real-time PCR in matched pooled and deconvoluted clinical samples before and after nucleic acid extraction: a study in tertiary care hospital of North India. Diagn Microbiol Infect Dis. 2021 Jan;99(1):115206. doi: 10.1016/j.diagmicrobio.2020.115206. 
 
S0732-8893(20)30583-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2020.115206</ArticleId><ArticleId IdType="pmc">PMC7486206</ArticleId><ArticleId IdType="pubmed">33045499</ArticleId></ArticleIdList></Reference><Reference><Citation>Ott IM, Strine MS, Watkins AE, Boot M, Kalinich CC, Harden CA, Vogels CB, Casanovas-Massana A, Moore AJ, Muenker MC, Nakahata M, Tokuyama M, Nelson A, Fournier J, Bermejo S, Campbell M, Datta R, Dela Cruz CS, Farhadian SF, Ko AI, Iwasaki A, Grubaugh ND, Wilen CB, Wyllie AL, Yale IMPACT Research team3 Stability of SARS-CoV-2 RNA in nonsupplemented saliva. Emerg Infect Dis. 2021 Apr;27(4):1146–1150. doi: 10.3201/eid2704.204199. doi: 10.3201/eid2704.204199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2704.204199</ArticleId><ArticleId IdType="doi">10.3201/eid2704.204199</ArticleId><ArticleId IdType="pmc">PMC8007305</ArticleId><ArticleId IdType="pubmed">33754989</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NT, Aprahamian H, Bish EK, Bish DR. A methodology for deriving the sensitivity of pooled testing, based on viral load progression and pooling dilution. J Transl Med. 2019 Aug 06;17(1):252. doi: 10.1186/s12967-019-1992-2. 
 
10.1186/s12967-019-1992-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-1992-2</ArticleId><ArticleId IdType="doi">10.1186/s12967-019-1992-2</ArticleId><ArticleId IdType="pmc">PMC6683472</ArticleId><ArticleId IdType="pubmed">31387586</ArticleId></ArticleIdList></Reference><Reference><Citation>Faruque MRJ, Bikker FJ, Laine ML. Comparing SARS-CoV-2 viral load in human saliva to oropharyngeal swabs, nasopharyngeal swabs, and sputum: a systematic review and meta-analysis. Can J Infect Dis Med Microbiol. 2023;2023:5807370. doi: 10.1155/2023/5807370. doi: 10.1155/2023/5807370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/5807370</ArticleId><ArticleId IdType="doi">10.1155/2023/5807370</ArticleId><ArticleId IdType="pmc">PMC10435302</ArticleId><ArticleId IdType="pubmed">37600753</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey SP, Williamson RT. A review of saliva: normal composition, flow, and function. J Prosthet Dent. 2001 Feb;85(2):162–9. doi: 10.1067/mpr.2001.113778.S0022-3913(01)54032-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mpr.2001.113778</ArticleId><ArticleId IdType="pubmed">11208206</ArticleId></ArticleIdList></Reference><Reference><Citation>Park NJ, Li Y, Yu T, Brinkman BMN, Wong DT. Characterization of RNA in saliva. Clin Chem. 2006 Jun;52(6):988–94. doi: 10.1373/clinchem.2005.063206. 
 
clinchem.2005.063206</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2005.063206</ArticleId><ArticleId IdType="pmc">PMC7108156</ArticleId><ArticleId IdType="pubmed">16601067</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahajpal NS, Mondal AK, Ananth S, Njau A, Ahluwalia P, Kota V, Caspary K, Ross TM, Farrell M, Shannon MP, Fulzele S, Chaubey A, Hegde M, Rojiani AM, Kolhe R. Clinical validation of a sensitive test for saliva collected in healthcare and community settings with pooling utility for severe acute respiratory syndrome coronavirus 2 mass surveillance. J Mol Diagn. 2021 Jul;23(7):788–795. doi: 10.1016/j.jmoldx.2021.04.005. 
 
S1525-1578(21)00114-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmoldx.2021.04.005</ArticleId><ArticleId IdType="pmc">PMC8129802</ArticleId><ArticleId IdType="pubmed">33957320</ArticleId></ArticleIdList></Reference><Reference><Citation>Valinetz ED, Cangelosi GA. A look inside: oral sampling for detection of non-oral infectious diseases. J Clin Microbiol. 2021 Sep 20;59(10):e0236020. doi: 10.1128/JCM.02360-20. 
 
JCM.02360-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02360-20?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1128/JCM.02360-20</ArticleId><ArticleId IdType="pmc">PMC8451410</ArticleId><ArticleId IdType="pubmed">33888590</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan SH, Allicock O, Armstrong-Hough M, Wyllie AL. Saliva as a gold-standard sample for SARS-CoV-2 detection. Lancet Respir Med. 2021 Jun;9(6):562–564. doi: 10.1016/S2213-2600(21)00178-8. 
 
S2213-2600(21)00178-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00178-8</ArticleId><ArticleId IdType="pmc">PMC8055204</ArticleId><ArticleId IdType="pubmed">33887248</ArticleId></ArticleIdList></Reference><Reference><Citation>Yee R, Truong TT, Pannaraj PS, Eubanks N, Gai E, Jumarang J, Turner L, Peralta A, Lee Y, Dien Bard J. Saliva is a promising alternative specimen for the detection of SARS-CoV-2 in children and adults. J Clin Microbiol. 2021 Jan 21;59(2):e02686-20. doi: 10.1128/JCM.02686-20. 
 
JCM.02686-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02686-20</ArticleId><ArticleId IdType="pmc">PMC8111155</ArticleId><ArticleId IdType="pubmed">33239380</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug Administration (FDA)  Coronavirus (COVID-19) update: FDA authorizes first diagnostic test using at-home collection of saliva specimens. FDA. 2020. May 08,  [2023-08-15].  
 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-diagnostic-test-using-home-collection-saliva
.</Citation></Reference><Reference><Citation>European Centre for Disease Prevention and Control (ECDC)  Considerations for the use of saliva as sample material for COVID-19 testing. ECDC. 2021.  [2023-08-15].  
 https://tinyurl.com/4t3spa9c
.</Citation></Reference><Reference><Citation>U.S. Food and Drug Administration (FDA)  Amending certain EUAs for RT-PCR molecular-based diagnostic tests to authorize the detection of nucleic acid from SARSCoV-2 from pooled anterior nasal respiratory specimens for screening when used as part of a serial testing program. FDA. 2021. Apr 20,  [2023-08-15].  
 https://www.fda.gov/media/147737/download
.</Citation></Reference><Reference><Citation>Fundación Biomédica Galicia Sur  Pooling Instituto de Investigación Sanitaria Galicia Sur (IISGS) IISGS. 2020.  [2023-08-15].  
 https://pooling.iisgaliciasur.es/
</Citation></Reference><Reference><Citation>Landra Sistemas  Pooling Vigo (Sample Registration) Pooling Vigo. 2020.  [2023-08-15].  
 https://poolingvigo.com/#/
</Citation></Reference><Reference><Citation>Hoebeeck J, Speleman F, Vandesompele J. Real-time quantitative PCR as an alternative to Southern blot or fluorescence in situ hybridization for detection of gene copy number changes. Methods Mol Biol. 2007;353:205–26. doi: 10.1385/1-59745-229-7:205.1-59745-229-7:205</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/1-59745-229-7:205</ArticleId><ArticleId IdType="pubmed">17332643</ArticleId></ArticleIdList></Reference><Reference><Citation>Augenblick N, Kolstad J, Obermeyer Z, Wang A. Pooled testing efficiency increases with test frequency. Proc Natl Acad Sci U S A. 2022 Jan 11;119(2):n.p. doi: 10.1073/pnas.2105180119. 
 
2105180119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2105180119</ArticleId><ArticleId IdType="pmc">PMC8764680</ArticleId><ArticleId IdType="pubmed">34983870</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC)  COVIDTracer and COVIDTracer Advanced. CDC. 2021. Jan 19,  [2023-08-15].  
 https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/COVIDTracerTools.html
.</Citation></Reference><Reference><Citation>Barak N, Ben-Ami R, Sido T, Perri A, Shtoyer A, Rivkin M, Licht T, Peretz A, Magenheim J, Fogel I, Livneh A, Daitch Y, Oiknine-Djian E, Benedek G, Dor Y, Wolf DG, Yassour M, Hebrew University-Hadassah COVID-19 Diagnosis Team  Lessons from applied large-scale pooling of 133,816 SARS-CoV-2 RT-PCR tests. Sci Transl Med. 2021 Apr 14;13(589):n.p. doi: 10.1126/scitranslmed.abf2823. 
 
scitranslmed.abf2823</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf2823?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.abf2823</ArticleId><ArticleId IdType="pmc">PMC8099176</ArticleId><ArticleId IdType="pubmed">33619081</ArticleId></ArticleIdList></Reference><Reference><Citation>Daon Y, Huppert A, Obolski U. An accurate model for SARS-CoV-2 pooled RT-PCR test errors. R Soc Open Sci. 2021 Nov;8(11):210704. doi: 10.1098/rsos.210704. 
 
rsos210704</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsos.210704?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1098/rsos.210704</ArticleId><ArticleId IdType="pmc">PMC8564620</ArticleId><ArticleId IdType="pubmed">34737873</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug Administration (FDA)  SARS-CoV-2 viral mutations: impact on COVID-19 tests. FDA. 2023. Sep 28,  [2023-08-15].  
 https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-viral-mutations-impact-covid-19-tests
.</Citation></Reference><Reference><Citation>Mardian Y, Kosasih H, Karyana M, Neal A, Lau C. Review of current COVID-19 diagnostics and opportunities for further development. Front Med (Lausanne) 2021;8:615099. doi: 10.3389/fmed.2021.615099. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.615099</ArticleId><ArticleId IdType="pmc">PMC8138031</ArticleId><ArticleId IdType="pubmed">34026773</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown KA, Gubbay J, Hopkins J, Patel S, Buchan SA, Daneman N, Goneau LW. S-gene target failure as a marker of variant B.1.1.7 among SARS-CoV-2 isolates in the Greater Toronto area, December 2020 to March 2021. JAMA. 2021 May 25;325(20):2115–2116. doi: 10.1001/jama.2021.5607. 
 
2778599</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5607</ArticleId><ArticleId IdType="pmc">PMC8033504</ArticleId><ArticleId IdType="pubmed">33830171</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges V, Sousa C, Menezes L, Gonçalves António Maia, Picão Miguel, Almeida JP, Vieita M, Santos R, Silva AR, Costa M, Carneiro L, Casaca P, Pinto-Leite P, Peralta-Santos A, Isidro J, Duarte S, Vieira L, Guiomar R, Silva S, Nunes B, Gomes JP. Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021. Euro Surveill. 2021 Mar;26(10):n.p. doi: 10.2807/1560-7917.ES.2021.26.10.2100130. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.10.2100130</ArticleId><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.10.2100130</ArticleId><ArticleId IdType="pmc">PMC7953529</ArticleId><ArticleId IdType="pubmed">33706862</ArticleId></ArticleIdList></Reference><Reference><Citation>Sánchez-Calvo Juan M, Alados Arboledas JC, Ros Vidal L, de Francisco JL, López Prieto María D. Diagnostic pre-screening method based on N-gene dropout or delay to increase feasibility of SARS-CoV-2 VOC B.1.1.7 detection. Diagn Microbiol Infect Dis. 2021 Dec;101(4):115491. doi: 10.1016/j.diagmicrobio.2021.115491. 
 
S0732-8893(21)00184-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2021.115491</ArticleId><ArticleId IdType="pmc">PMC8282941</ArticleId><ArticleId IdType="pubmed">34464903</ArticleId></ArticleIdList></Reference><Reference><Citation>Centro de Coordinación de Alertas y Emergencias Sanitarias  Actualización de la situación epidemiológica de las variantes de SARS-CoV-2 en España. Ministerio de Sanidad. 2023. May 23,  [2023-08-15].  
 https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Actualizacion_variantes_20230522.pdf
.</Citation></Reference><Reference><Citation>Cabrera Alvargonzález Jorge, Larrañaga Janeiro Ana, Pérez Castro Sonia, Martínez Torres Javier, Martínez Lamas Lucía, Daviña Nuñez Carlos, Del Campo-Pérez Víctor, Suarez Luque S, Regueiro García Benito, Porteiro Fresco J. Proof of concept of the potential of a machine learning algorithm to extract new information from conventional SARS-CoV-2 rRT-PCR results. Sci Rep. 2023 May 13;13(1):7786. doi: 10.1038/s41598-023-34882-6. doi: 10.1038/s41598-023-34882-6.10.1038/s41598-023-34882-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-34882-6</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-34882-6</ArticleId><ArticleId IdType="pmc">PMC10182547</ArticleId><ArticleId IdType="pubmed">37179356</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabzevari Alireza Ghannad, Nikbakht M. Considerations about reducing false-negative PCR test for COVID-19. Int J MCH AIDS. 2022;11(2):e571. doi: 10.21106/ijma.571. 
 
IJMA-11-e571</Citation><ArticleIdList><ArticleId IdType="doi">10.21106/ijma.571</ArticleId><ArticleId IdType="pmc">PMC9713756</ArticleId><ArticleId IdType="pubmed">36466768</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020 May;20(5):533–534. doi: 10.1016/S1473-3099(20)30120-1. 
 
S1473-3099(20)30120-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhsen K, Maimon N, Mizrahi A, Varticovschi B, Bodenheimer O, Gelbshtein U, Grotto I, Cohen D, Dagan R. Effects of BNT162b2 Covid-19 vaccine booster in long-term care facilities in Israel. N Engl J Med. 2022 Jan 27;386(4):399–401. doi: 10.1056/NEJMc2117385. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2117385</ArticleId><ArticleId IdType="pmc">PMC8757568</ArticleId><ArticleId IdType="pubmed">34936758</ArticleId></ArticleIdList></Reference><Reference><Citation>Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021 Oct;21(10):626–636. doi: 10.1038/s41577-021-00592-1. 
 
10.1038/s41577-021-00592-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00592-1</ArticleId><ArticleId IdType="pmc">PMC8351583</ArticleId><ArticleId IdType="pubmed">34373623</ArticleId></ArticleIdList></Reference><Reference><Citation>North CM, Barczak A, Goldstein RH, Healy BC, Finkelstein DM, Ding DD, Kim A, Boucau J, Shaw B, Gilbert RF, Vyas T, Reynolds Z, Siddle KJ, MacInnis BL, Regan J, Flynn JP, Choudhary MC, Vyas JM, Laskowski K, Dighe AS, Lemieux JE, Li JZ, Baden LR, Siedner MJ, Woolley AE, Sacks CA. Determining the incidence of asymptomatic SARS-CoV-2 among early recipients of COVID-19 vaccines (DISCOVER-COVID-19): a prospective cohort study of healthcare workers before, during and after vaccination. Clin Infect Dis. 2022 Apr 09;74(7):1275–1278. doi: 10.1093/cid/ciab643. 
 
6345339</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab643</ArticleId><ArticleId IdType="pmc">PMC8436402</ArticleId><ArticleId IdType="pubmed">34363462</ArticleId></ArticleIdList></Reference><Reference><Citation>Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J, COVID-19 Genomics UK Consortium. Peacock SJ, Barclay WS, de Silva TI, Towers GJ, Robertson DL. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol. 2023 Mar;21(3):162–177. doi: 10.1038/s41579-022-00841-7. 
 
10.1038/s41579-022-00841-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00841-7</ArticleId><ArticleId IdType="pmc">PMC9847462</ArticleId><ArticleId IdType="pubmed">36653446</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo-Bravo R, Lucca N, Lai L, Marlborough K, Brychkova G, Sakhteh MS, Lonergan C, O'Grady Justin, Alikhan N, Trotter AJ, Page AJ, Smyth B, McKeown PC, Feenstra JDM, Ulekleiv C, Sorel O, Gandhi M, Spillane C. Clinical performance of direct RT-PCR testing of raw saliva for detection of SARS-CoV-2 in symptomatic and asymptomatic individuals. Microbiol Spectr. 2022 Dec 21;10(6):e0222922. doi: 10.1128/spectrum.02229-22. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02229-22?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1128/spectrum.02229-22</ArticleId><ArticleId IdType="pmc">PMC9769602</ArticleId><ArticleId IdType="pubmed">36409097</ArticleId></ArticleIdList></Reference><Reference><Citation>Corey L, Beyrer C, Cohen MS, Michael NL, Bedford T, Rolland M. SARS-CoV-2 variants in patients with immunosuppression. N Engl J Med. 2021 Aug 05;385(6):562–566. doi: 10.1056/NEJMsb2104756. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb2104756</ArticleId><ArticleId IdType="pmc">PMC8494465</ArticleId><ArticleId IdType="pubmed">34347959</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnleitner ST, Prelog M, Sonnleitner S, Hinterbichler E, Halbfurter H, Kopecky DBC, Almanzar G, Koblmüller Stephan, Sturmbauer C, Feist L, Horres R, Posch W, Walder G. Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host. Nat Commun. 2022 May 10;13(1):2560. doi: 10.1038/s41467-022-30163-4. doi: 10.1038/s41467-022-30163-4.10.1038/s41467-022-30163-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30163-4</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-30163-4</ArticleId><ArticleId IdType="pmc">PMC9090742</ArticleId><ArticleId IdType="pubmed">35538074</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagchi S, Mak J, Li Q, Sheriff E, Mungai E, Anttila A, Soe MM, Edwards JR, Benin AL, Pollock DA, Shulman E, Ling S, Moody-Williams J, Fleisher LA, Srinivasan A, Bell JM. Rates of COVID-19 among residents and staff members in nursing homes - United States, May 25-November 22, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):52–55. doi: 10.15585/mmwr.mm7002e2. doi: 10.15585/mmwr.mm7002e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7002e2</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm7002e2</ArticleId><ArticleId IdType="pmc">PMC7808710</ArticleId><ArticleId IdType="pubmed">33444301</ArticleId></ArticleIdList></Reference><Reference><Citation>Priya Chidambaram. Over 200,000 residents and staff in long-term care facilities have died from COVID-19. KFF. 2022. Feb 03,  [2023-08-15].  
 https://www.kff.org/policy-watch/over-200000-residents-and-staff-in-long-term-care-facilities-have-died-from-covid-19/#:~:text=More%20than%20200%2C000%20long%2Dterm,deaths%20over%20this%20bleak%20milestone
.</Citation></Reference><Reference><Citation>Geoghegan JL, Holmes EC. The phylogenomics of evolving virus virulence. Nat Rev Genet. 2018 Dec;19(12):756–769. doi: 10.1038/s41576-018-0055-5. 
 
10.1038/s41576-018-0055-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-018-0055-5</ArticleId><ArticleId IdType="pmc">PMC7096893</ArticleId><ArticleId IdType="pubmed">30305704</ArticleId></ArticleIdList></Reference><Reference><Citation>Escobar M, Jeanneret G, Bravo-Sánchez Laura, Castillo A, Gómez Catalina, Valderrama D, Roa M, Martínez Julián, Madrid-Wolff J, Cepeda M, Guevara-Suarez M, Sarmiento OL, Medaglia AL, Forero-Shelton M, Velasco M, Pedraza JM, Laajaj R, Restrepo S, Arbelaez P. Smart pooling: AI-powered COVID-19 informative group testing. Sci Rep. 2022 Apr 20;12(1):6519. doi: 10.1038/s41598-022-10128-9. doi: 10.1038/s41598-022-10128-9.10.1038/s41598-022-10128-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10128-9</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-10128-9</ArticleId><ArticleId IdType="pmc">PMC9020431</ArticleId><ArticleId IdType="pubmed">35444162</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobczyk J, Pyne MT, Barker A, Mayer J, Hanson KE, Samore MH, Noriega R. Efficient and effective single-step screening of individual samples for SARS-CoV-2 RNA using multi-dimensional pooling and Bayesian inference. J R Soc Interface. 2021 Jun;18(179):20210155. doi: 10.1098/rsif.2021.0155. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2021.0155?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1098/rsif.2021.0155</ArticleId><ArticleId IdType="pmc">PMC8205536</ArticleId><ArticleId IdType="pubmed">34129787</ArticleId></ArticleIdList></Reference><Reference><Citation>Instituto de Salud Carlos III. Centro Nacional de Epidemiología  Informe SiVIRA de Vigilancia de gripe, COVID-19 y VRS España, temporada 2021-2022. Instituto de Salud Carlos III. 2022. Sep,  [2023-08-15].  
 https://tinyurl.com/yc5aw3aa
.</Citation></Reference><Reference><Citation>Liu Y, Yin Y, Ward MP, Li K, Chen Y, Duan M, Wong PPY, Hong J, Huang J, Shi J, Zhou X, Chen X, Xu J, Yuan R, Kong L, Zhang Z. Optimization of screening strategies for COVID-19: scoping review. JMIR Public Health Surveill. 2024 Feb 27;10:e44349. doi: 10.2196/44349. 
 
v10i1e44349</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/44349</ArticleId><ArticleId IdType="pmc">PMC10933748</ArticleId><ArticleId IdType="pubmed">38412011</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilera A, Fuentes A, Cea M, Carracedo R, Viñuela Laura, Ordóñez Patricia, López-Fabal Fátima, Sáez Elena, Cebrián Rubén, Pérez-Revilla Alfredo, Pereira S, De Salazar A, García Federico. Real-life validation of a sample pooling strategy for screening of hepatitis C. Clin Microbiol Infect. 2023 Jan;29(1):112.e1–112.e4. doi: 10.1016/j.cmi.2022.09.006. 
 
S1198-743X(22)00474-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.09.006</ArticleId><ArticleId IdType="pubmed">36210627</ArticleId></ArticleIdList></Reference><Reference><Citation>Pritt BS. Home self-collection and specimen pooling: tools for convenient and economical detection of sexually transmitted infections. Clin Infect Dis. 2021 Nov 02;73(9):e3194–e3195. doi: 10.1093/cid/ciaa1550.5921148</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1550</ArticleId><ArticleId IdType="pubmed">33045071</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Aboud L, Chow EPF, Mello MB, Wi T, Baggaley R, Fairley CK, Peeling R, Ong JJ. The diagnostic accuracy of pooled testing from multiple individuals for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae: a systematic review. Int J Infect Dis. 2022 May;118:183–193. doi: 10.1016/j.ijid.2022.03.009. 
 
S1201-9712(22)00147-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.03.009</ArticleId><ArticleId IdType="pubmed">35283298</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuchas C, Teyim P, Dang BF, Neh A, Keugni L, Che M, Che PN, Beloko H, Fondoh V, Ndi NN, Wandji IAG, Fundoh M, Manga H, Mbuli C, Creswell J, Bisso A, Donkeng V, Sander M. Implementation of large-scale pooled testing to increase rapid molecular diagnostic test coverage for tuberculosis: a retrospective evaluation. Sci Rep. 2023 Sep 16;13(1):15358. doi: 10.1038/s41598-023-41904-w. doi: 10.1038/s41598-023-41904-w.10.1038/s41598-023-41904-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-41904-w</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-41904-w</ArticleId><ArticleId IdType="pmc">PMC10505184</ArticleId><ArticleId IdType="pubmed">37717043</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kerkhove MD, Ryan MJ, Ghebreyesus TA. Preparing for "Disease X". Science. 2021 Oct 22;374(6566):377. doi: 10.1126/science.abm7796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm7796</ArticleId><ArticleId IdType="pubmed">34643114</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter LL, Yu MA, Sacks JA, Barnadas C, Pereyaslov D, Cognat S, Briand S, Ryan MJ, Samaan G. Global genomic surveillance strategy for pathogens with pandemic and epidemic potential 2022-2032. Bull World Health Organ. 2022 Apr 01;100(4):239–239A. doi: 10.2471/BLT.22.288220. 
 
BLT.22.288220</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.22.288220</ArticleId><ArticleId IdType="pmc">PMC8958828</ArticleId><ArticleId IdType="pubmed">35386562</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)   WHO. Geneva, Switzerland: WHO;  [2023-08-15]. Prioritizing diseases for research and development in emergency contexts. 
 https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts
.</Citation></Reference><Reference><Citation>Zenodo  Large-scale saliva pooling as a screening strategy to control transmission raw data. Zenodo. 2023. Apr 10,  [2024-08-15].  
 https://zenodo.org/record/7813744#.ZDgP23ZBxD8
.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>